ExecEdge – Page 67

SkylineDx’s Merlin Test Shows Predictive Accuracy in Early-Stage Melanoma

By Karen Roman SkylineDx said its Merlin CP-GEP molecular test identifies a subset of T1a melanoma patients with sentinel lymph node (SLN) positivity above guideline...

SkylineDx’s Merlin Test Shows Predictive Accuracy in Early-Stage Melanoma

Tech Edge Live from RSA Conference 2026 with Qualys, AvePoint, SailPoint

Brazil Potash Nears Construction Milestones, Eyes Funding Breakthrough – Quarterly Update Report

Munchkin Creates Formula Giveaway Program for TSA Families